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Abstract 
 
Pharmaceuticals and their derivatives are considered emerging organic contaminants of aquatic 
ecosystems, mostly by inputs from domestic and hospital effluents. The toxicological risk 
associated to these substances results essentially from their ability to act on a specific metabolic 
process. These substances have been revealed toxic to aquatic organisms as well as to the human 
populations that depend on these ecosystems. However, the toxicity of pharmaceuticals in the 
environment is not yet well known, such as for simvastatin, which is a human drug used for the 
treatment of high levels of cholesterol. The amphipod Gammarus locusta is a species with high 
ecological relevance and high importance in toxicological studies, both acute and chronic. 
However, histopathological appraisals on these organisms are almost absent. Gammarus locusta 
(newborn) were exposed to a chronic assay with a broad range of sublethal concentrations of 
simvastatin. At the end of their life cycle, males and females were subjected to a histopathological 
evaluation using histochemical techniques for light bright-field and fluorescence microscopy, 
considering the hepatopancreas as the main target-organ. The comparison between the control 
treatment and the organisms exposed to several concentrations of the pharmaceutical permitted the 
selection and evaluation of qualitative and quantitative histopathological biomarkers. The results 
show non-monotonic dose-response curves that support the physiological alterations on the 
hepatopancreas epithelium reflecting alterations in the metabolism of carbohydrates, enzymatic 
activity and lipid storage. However, no evidence of severe lesions in this and other organs could be 
related to exposure. Females presented a higher ability to react to the pharmaceutical than males, 
when exposed to the lower concentrations of simvastatin. This can be connected with the higher 
energy reserves of females, associated in part to their reproductive functions. In conclusion, 
simvastatin affects amphipod metabolism that is responsible by alterations on cellular structures of 
the hepatopancreas, revealing thus more important physiological alterations than direct damage 
induced by the pharmaceutical. 
 
 
Keyword: Amphipod, Pharmaceuticals, Histology, Histopathology, Toxicity Bioassays, 
Hepatopancreas 
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Resumo 
 
Os fármacos e seus derivados são considerados contaminantes orgânicos emergentes que poluem os 
ecossistemas aquáticos principalmente através de efluentes domésticos e hospitalares. O risco 
toxicológico associado a estas substâncias resulta principalmente da sua actuação sobre um 
processo metabólico específico. Estas substâncias têm-se revelado tóxicas para os organismos 
aquáticos e para as populações humanas que dependem destes ecossistemas. A toxicidade 
associada aos fármacos, no entanto, não é ainda bem conhecida, tal como para a sinvastatina, um 
fármaco humano utilizado no tratamento de altos níveis de colesterol. O anfípode Gammarus 
locusta é uma espécie com elevada relevância ecológica e muito importante em estudos 
toxicológicos agudos e crónicos. No entanto, análises histopatológicas nestes organismos estão 
praticamente ausentes em estudos toxicológicos. Gammarus locusta (recém nascidos) foram 
expostos, num ensaio crónico, a uma gama alargada de concentrações sub-letais de sinvastatina. No 
final do seu ciclo de vida, machos e fêmeas, foram sujeitos a avaliação histopatológica recorrendo a 
técnicas histoquímicas de microscopia de campo claro e de fluorescência, tendo como principal 
órgão-alvo o hepatopâncreas. A comparação entre o tratamento-controlo e os organismos expostos 
às várias concentrações do fármaco permitiu a selecção e avaliação de biomarcadores 
histopatológicos qualitativos e quantitativos. Os resultados apresentam uma curva dose-resposta 
não-linear e evidenciam alterações fisiológicas no epitélio do hepatopâncreas que reflectem 
alterações no metabolismo de hidratos de carbono, actividade enzimática e armazenamento de 
lípidos. No entanto, não puderam ser associadas, em vários órgãos, lesões histopatológicas graves à 
exposição ao fármaco. As fêmeas apresentam uma maior capacidade de reacção ao fármaco do que 
os machos, quando expostas a baixas concentrações de sinvastatina. Tal pode estar ligado às altas 
reservas energéticas das fêmeas associadas, em parte, às suas funções reprodutivas. Em conclusão, 
a sinvastatina afecta o metabolismo do anfípode provocando alterações nas estruturas celulares do 
hepatopâncreas, o que evidencia um maior impacto fisiológico, em detrimento de lesões 
directamente causadas pela substância. 
 
 
Palavras-chave: Anfípode, Fármacos, Histologia, Histopatologia, Bioensaios de toxicidade, 
Hepatopâncreas 
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1. Introduction 
 
Aquatic pollution is a serious threat with numerous consequences for communities in the aquatic 
environment and consequently for other animals and plants in land, as well as for humans exposed 
to environmental toxicants via water, air and food. The water masses are subjected to many 
toxicological pressures from human activities, such as industry, urbanism and agriculture; and also 
those deriving from the increasing production, use and release of the veterinary and human 
pharmaceuticals (EEA, 2010). The European Union responded to the increasing threat of water 
pollution by publishing, in 2000, the Water Framework Directive (WFD, Directive 2000/60/EC), 
which was latter complemented with the Marine Strategy Framework Directive (MSFD, Directive 
2008/56/EC). Altogether, these two directives established guidelines and standards to monitor and 
minimize adverse anthropogenic impacts to aquatic ecosystems, including those related to the 
inputs of hazardous substances. The water quality monitoring is thus an important component 
addressed by both directives, in order to safeguard environmental quality. However, environmental 
monitoring of aquatic environments is challenging, in large part due to the complexity of these 
ecosystems. Nonetheless, there are, nowadays, several analytical tools that may be employed to the 
purpose, from passive biomonitoring (i.e. in situ sampling), biomarkers to determine the effects and 
responses of organisms to bioassays to test substances and determine their thresholds of toxicity, as 
well as their effects to organisms (see Chapman, 2007).  
 
In the past few years, a new set of aquatic pollutants has been emerging as an environmental threat, 
being termed emerging organic contaminants (EOCs), which are synthetic or semi-synthetic 
substances that present a potential risk for environmental ecosystems and human health (Farré et 
al., 2008). The EOC class of toxicants includes pharmaceuticals, day-care products, endocrine 
disruptors (including hormone-mimicking substances), surfactants, perfluorinated compounds 
(PFCs), flame retardants, industrial additives and agents, gasoline additives and others, including 
their metabolites (Farré et al., 2008). Among EOCs, pharmaceuticals pose a particular threat for 
affecting specific biological pathways albeit often reaching the aquatic media as biotransformed 
metabolites, for which toxicological effects are difficult to predict (Farré et al., 2008).  
 
Pharmaceutical production and prescription use has been growing over the last decades, whereas 
urban wastewater treatment facilities are ineffective in the elimination of these compounds and 
their metabolites (EEA, 2010). For instance, Verlicchi et al. (2012) detected, in wastewater 
effluents, a wide range of pharmaceuticals, such as antibiotics, anti-inflammatory drugs and lipid 
regulators, however in low concentrations, presumable signifying a moderate risk for aquatic 
communities. However, these “low” concentrations, in the long term represented a sizable risk for 
aquatic organisms, which presented chronic effects derived from increase of the contaminant 
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individual concentration or from the pollutants mixture presence, in the aquatic system (Verlicchi 
et al., 2012). To the Water Framework Directive is appended the Priority Substances List, 
providing guidelines to monitor hazardous chemicals in water masses. Still, pharmaceuticals, as 
simvastatin, are not yet included in the list, probably due to the general lack of knowledge about 
these substances. Nonetheless, pharmaceuticals are expected to integrate the Priority Substances 
List in the next few years, as a result of the increasing concern on EOCs.  
 
Simvastatin (C25H38O5) is a commercial drug included in the statins family, prescribed to humans 
for the treatment of blood hyperlipidemia (Mauro, 1993). The substance is a semi-synthetic drug 
analogue to lovastatin, which is a fermentation product of the fungus Aspergillus terreus in 
presence of a carbon-rich medium (Mauro, 1993; Casas López et al., 2004) but has up to five times 
greater potency than lovastatin, as demonstrated in vitro (Desager and Horsmans, 1996). The main 
mode of action of simvastatin is the inhibition of the enzyme 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) reductase, which contributes to lower squalene (a precursor of 
cholesterol) synthesis, as well as the synthesis of other important sub-products of mevalonate 
pathway as ubiquinone (coenzyme Q), dolichol (involved in protein glycosylation), and compounds 
that interfered in protein synthesis and tRNA modification (Gerson et al., 1989; Desager and 
Horsmans, 1996; Bentinger et al., 2010). In water, the drug is insoluble but it is soluble in common 
organic solvents such as chloroform, alcohol and methanol (Mauro, 1993). In mammals, 
simvastatin bioaccumulates mostly in the liver, where it is metabolized by the action of cytochome 
P450 (CYP) monooxygenases resulting in several metabolites among which are included 
simvastatin acid, which is the principal active form associated to HMG-CoA reductase inhibition 
(Mauro, 1993; Desager and Horsmans, 1996; Patil et al., 2007; Key et al., 2008). Desager and 
Horsmans (1996) also refer that simvastatin decreases acyl coenzyme A acyltransferase (ACAT) 
activity, an enzyme that is responsible for cholesterol absorption directly from the diet. Thus, lower 
simvastatin doses decrease cholesterol synthesis and absorption; however also reducing ubiquinone 
production, which acts as antioxidant, and interferes with the process of energy production (Walton 
and Pennock, 1972; Velho et al., 2006; Bentinger et al., 2010). At high dosages, simvastatin is 
toxic for several animals, being able to cause hepatic necrosis and multiple other lesions in various 
tissues. Gerson et al. (1989) studied the simvastatin effects in several mammals with ingestion of 
the simvastatin doses, up of the doses prescribed for human treatment (5 at 40 mg.day
-1
), and 
conclude that higher doses are responsible for liver lesions and necrosis in renal tubule in rabbits, 
while the dogs may develop cataracts. Also, Horsmans et al. (1990) found a high level of 
hepatotoxic effect in liver of the guinea-pigs subjected to simvastatin doses of 125 mg.kg
-1
.day
-1
. In 
invertebrates, higher doses of simvastatin affect essentially the enzymatic system and consequently 
the total metabolism and energy production, as observed by Dahl et al. (2006), eliciting also a 
decrease of RNA content and elevated mortality in copepods. High doses of simvastatin and/or in 
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combination with other drugs, may even increase the risk of myopathy (lesions in muscular fibers), 
including rhabdomyolysis (necrosis of muscle cells with release of catalytic products to the blood 
stream, increasing the risk of renal insufficiency) (see Omar et al., 2001). In crustacean, simvastatin 
can affected the production of hormones that regulate molting, reproduction and growth (Chang, 
1995; Li et al., 2003). The inhibition of HMG-CoA reductase, acts in reduction of the methyl 
farnesoate, a compound related to insect juvenile hormone, and consequently the reduction of 
vitellogenesis (Li et al., 2003). In fact, Zapata et al. (2002) observed in female insects a reduction 
of the reproduction; and for higher concentrations of stains the embryogenesis is blocked and 
females present 100% of sterility. 
 
The amphipod Gammarus locusta is a marine and epibenthic crustacean that inhabits medium to 
low intertidal zones, having a large biogeographic distribution in European costal systems, 
including Portuguese costal ecosystems, where the species is abundant. The species feeds mainly 
on microalgae, Ulva spp. and Enteromorpha spp., however it has been verified in laboratory studies 
that Gammarus locusta can be omnivorous, herbivore, detritivore, and even prone for cannibalism 
(see Costa and Costa, 2000). According with the study of Neuparth et al. (2002) the ideal 
temperature and salinity for the rearing of the species are variable but usually within 15⁰C to 20⁰C 
with a salinity of 33 and around 15 ºC between 20 and 33 (for acute and chronic assays). 
Gammarus locusta is a species with high ecological relevance and high sensitivity to contaminants 
in aquatic environment, which, together with short life cycle and ease to breed in the laboratory, 
permits evaluating the effects of contaminants along their life cycle, following chronic exposure to 
toxicants (e.g. Costa and Costa, 2000; Costa et al., 2005; Neuparth et al., 2005). Nevertheless, this 
species, as for other amphipods, is more commonly utilized to determinate survival, growth and 
reproductive rates following acute exposure to toxicants in water and sediments. Several fully 
standardized protocols have been developed for acute and chronic tests with amphipods, such as 
the protocol developed for five amphipod species by American Society for Testing and Materials 
(ASTM, 1992). In Europe, standard protocols have been developed and published for marine and 
estuarine whole-sediment tests with the species Corophium volutator (Bat and Raffaelli, 1998) and 
Gammarus locusta (Costa et al., 1998). Numerous studies on acute and chronic exposure have been 
developed with amphipods; however, histopathological evaluations are almost nonexistent. Still, 
Correia et al. (2002) presents a study of histological description of the hepatopancreas but the work 
did not involve toxicity assays, being an exception amidst the otherwise lack of knowledge on 
amphipod histology. 
 
Biomarkers may indicate the biological response to an environmental chemical, which are observed 
and measured inside of an organism indicating a deviation from the normal status that cannot be 
detected in the intact organism (van der Oost et al., 2003). The classic biomarkers are divided in 
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three types: biomarkers of exposure, biomarkers of effect and biomarkers of susceptibility (NRC, 
1987). Histopathological biomarkers are not explicitly inserted in one of these types because have 
characteristics similar to all. Histopathological biomarkers are based on alterations of 
micromorphology and cell physiology of the organisms when exposed to contaminant that are 
potentially indicative of exposure to toxicants. The histopathological evaluation permits 
indentifying the organ or tissue primarily affected by contaminants and allows the demonstration of 
structurals alterations that may result from contaminant interference in metabolic processes, such as 
energy reserve and metabolism, cell cycle, etc. (van der Oost et al., 2003). Additionally, 
histopathology provides tools for aquatic systems monitoring to the level of the organism health 
status that are easy to understand by the general public and legislators. However, the use of 
histopathology in monitoring programs is frequently reduced in comparison to other biomarker 
responses (e.g. biochemical) mostly because there is a lack of a clear knowledge on microanatomy 
and micropathology of organisms, especially invertebrates (Au, 2004). Histopathological 
biomarkers can be purely qualitative, i.e. limited to a description of lesions and alterations; semi-
quantitative, permitting a more objective evaluation through the attribution of some sort of 
empirical scores to classify the levels of change in the tissue; and quantitative, an assessment that 
allows objective quantification of alterations by direct measurements of histological and 
cytological structures. Semi-quantitative evaluations can reveal lack of objectivity and consensus in 
the identification of the histopathological lesions and attribution of scores, which may impair the 
final assessment of the real effects or responses to contaminant (Costa et al., 2011). However 
quantitative evaluations circumvent most of these limitations, since measurements are made 
directly from histological screening. Nonetheless, all these three types of histopathological 
biomarkers complement the total chronic effects evaluation in an organism exposed to sublethal 
concentrations of the contaminant. 
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2. Objectives 
 
The main objective of this thesis is to evaluate the histopathological alterations in whole mid-body 
sections the amphipod, Gammarus locusta, exposed to several concentrations (between 0 to 8 μg.L
-
1
) of an emerging pollutant, the pharmaceutical, simvastatin. The hepatopancreas, in crustaceans, is 
the main organ with xenobiotic metabolization functions, similar to the mammalian liver and, for 
this reason, it was the main organ chosen to quantitatively evaluate histopathological alterations 
eventually dose-dependent to pharmaceutical exposure, which implicates the identification 
appropriate biomarkers and correlate the results with simvastatin concentrations. As a secondary 
objective, sections were screened for qualitative alterations, such as hemocyte infiltration, as a sign 
of inflammation. Additionally, the work intend to assess differences between males and females, 
i.e., to assess sexual dimorphism regarding the effects and responses of amphipods exposed to 
simvastatin. Finally, it is intended, through microscopy observations, to contribute to the 
knowledge of amphipod microanatomy.  
 
In brief, the main points to approach in this thesis are: 
 
 To identify the histopathological alterations in hepatopancreas of amphipod Gammarus 
locusta exposed to an emerging pollutant, the pharmaceutical simvastatin; 
 
 To identify qualitative and fully quantitative biomarkers, the latter in the hepatopancreas, for 
being the main xenobiotic transformation and storage organ; 
 
 To look for potential dose-effect relationships between concentration of exposure and the 
histopathological measurements considered as candidate biomarkers; 
 
 To survey potential differences, with respect to the mode of reaction to this toxicant, between 
males and females; 
 
 To contribute to a histological description of the amphipod Gammarus locusta. 
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3. Materials and Methods 
 
3.1. Experimental procedure 
 
Amphipods, Gammarus locusta, were exposed to simvastatin during all life cycle (from newborn to 
maturation), which extended for 72 or 47 days at 18 or 20 ⁰C, respectively. The amphipods, fifty 
neonates (< 7 days-old) per replicate, were exposed in 5 L glass aquaria, salinity between 33-35 
and photoperiod set at 16:8 h light:dark. A 1cm deep layer of natural sediment was placed in each 
aquarium the day before the start of the assay. Aeration was provided with plastic tips placed at 
least 1 cm above the sediment surface. Pebbles were added to provide shelter. The animals were 
divided by six treatment groups with four replicates. The individuals were randomly selected and 
placed in each aquarium, expectedly males and females in identical proportions. The treatment 
groups represent simvastatin nominal concentrations of 0.064, 0.32, 1.6 and 8 μg.L
-1
 (dissolved in 
acetone), plus control (acetone only) and blank groups. The animals were fed daily with Ulva 
lactuca. Water changes (100%) were performed twice a week (followed by recontamination) to 
ensure constancy of water quality. At the end of the exposure period, at least six males and six 
females per treatment were sampled for histological analyses.  
 
3.2. Histological procedures 
 
Animals (females and males) were sectioned dorsoventrally through the mid-body plan and fixed in 
Bouin-Hollande’s solution (10% v/v formaldehyde and 7% v/v acetic acid to which picric acid was 
added till saturation) or in Carnoy’s fixative (absolute ethanol, chloroform, glacial acetic acid 
6:3:1) for 24h at 4 ⁰C. After fixation, the Bouin-fixed samples were washed in distilled water, 
dehydrated in a progressive series of ethanol (70, 96 and 100%), infiltrated in xylenes and 
embedded in paraffin. Carnoy-fixed samples were washed in absolute ethanol and processed to 
paraffin as previous. Details on the procedures are described by Martoja and Martoja (1967) and 
Puchtler (1968).  
 
Paraffin-embedded samples were sectioned (5 μm thickness) with a Jung RM2035 model rotary 
microtome (Leica Microsystems). At least two slides per individual were obtained, each containing 
a minimum of eight serial sections. The samples were deparaffinated in xylene, rehydrated in a 
regressive series of ethanol (100, 96 and 70%), washed in distilled water and stained by a 
tetrachrome stain (TC) (for bright-field microscopy) based on Alcian Blue, Periodic Acid-Schiff’s, 
Weigert’s Hematoxylin and Picric Acid (Costa and Costa, 2012, with few modifications) or with 
the Acridine Orange stain (AO) for nucleic acids (fluorescence microscopy) in histological samples 
(Costa and Costa, 2008). 
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The tetrachrome stain allows the structural visualization and detection of basic (bright pink) and 
acid (blue) polysaccharides with application of Periodic Acid-Schiff’s and Alcian Blue 
histochemical dyes, respectively (Costa et al., 2012). Weigert’s Hematoxylin stains the nuclei and 
other basophilic structures with brown/black, and the muscle fibers are stained yellow by Picric 
Acid. Briefly: after deparaffination and rehydration, sections were stained with Alcian Blue (30 
min), followed by treatment with Periodic acid (5 min) and staining with Schiff’s reagent (15 min). 
Samples were counterstained with Weigert’s Hematoxylin (5 min) and heated (60 ºC) Picric acid (5 
min). All other steps were performed at room temperature and in the dark. Intermediate washing 
steps were done with Milli-Q grade ultrapure water (> 16.2 M cm). The slides were afterwards 
dehydrated in a progressive series of ethanol (70, 95 and 100%), cleared with xylene, allowed to 
dry completely and mounted with DPX resin. 
 
The Acridine Orange stain was employed to enhance the contrast of cellular structures such as 
nuclei and endoplasmatic reticuli (see Costa and Costa 2008). Acridine Orange is metachromatic 
(yellowish) for double strand nucleic acids (as nuclear DNA) and ortochromatic (reddish) for single 
strand nucleic acids (such as ribosomal RNA), while background remains greenish. Slides were 
stained in Acridine Orange (0.01 % m/v AO base in 0.1 % v/v acetic acid) for 45 minutes at room 
temperature, in the dark, after which the slides were briefly rinsed in AO washing solution (0.5% 
acetic acid in ethanol) to remove the excessive dye. The slides were then dehydrated with 100% 
ethanol, cleared and mounted as previously described. 
 
3.3. Histopathlogical observations 
 
The analyses were carried out using a DMLB model microscope adapted for epifluorescence with 
an EL2000 UV source and an I3 filter, coupled to a DFC480 model digital camera (all from Leica 
Microsystems, Germany).  
 
A preliminary qualitative histopathological screening was performed on the internal structure of the 
animals in order to look for alterations such as morphological changes, infiltrating hemocytes and 
necrotic foci. The quantitative histopathological approach was performed on the epithelia of 
digestive gland tubules (hepatopancreas), for this being the organ potentially involved in toxicant 
storage and detoxification, similarly to the vertebrate liver (Saravana Bhavan and Geraldine, 2000; 
Wu et al., 2008; Walker et al., 2010). Accordingly, measurements were performed on: thickness of 
tubular epithelia; number of vacuoles (non-digestive), non-digestive vacuole diameter and cell type 
ratios. Cell types were classified into F (Fibrillar)-cells with one fibrillar appearance, digestive 
enzymes synthesis and a developed rough endoplasmic reticulum (Al-Mohanna et al., 1985); R 
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(Resorptive)-cells are resorptive or absorptive cells with abundant vacuoles containing lipids and 
glycogen (Al-Mohanna and Nott, 1987); and B (Blister-like)-cells with a large digestive vacuole 
responsible for intra-cellular digestion and material elimination (Al-Mohanna and Nott, 1986). All 
measurements, counts and ratios were obtained from random intact sections and averaged per 
individual.  
 
Measurements were made using the Image J software (National Institutes for Health, USA). The 
thickness of tubular epithelium was calculated by measuring the thickness of at least eight intact 
tubule sections (minimum of twenty measurements per sample). Vacuolar diameter was calculated 
by measuring the vacuole diameters of twenty-five epithelial cells per sample (minimum of twenty-
five measurements per sample). The mean number of non-digestive vacuoles per cell was estimated 
from counting on at least twenty-five epithelial cells.  
 
3.4. Statistical analyses 
 
Quantitative variables were compared between treatments through the nonparametric Mann-
Whitney U test and the Spearman rank-order correlation R statistic were employed at all the 
treatments, with differentiation between males and females. Non-parametric statistics were 
employed after invalidation of at least one of the assumption of parametric tests, namely 
homogeneity of variances (homocedasticity) and normality (determined through Levene’s and 
Kolmogoroff-Smirnoff’s, respectively. Principal component analysis (correlation-based) was 
employed to determine links between variables and the nominal concentrations of simvastatin. A 
significance level α was set at 0.05 for all analyses. All statistics were performed with Statistica 
(Statsoft, USA). 
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4. Results 
 
4.1. Microanatomy of Gammarus locusta 
 
Gammarus locusta presented a simple internal structure (Figure 1 A), with a mildly PAS-positive 
(light pink) exoskeleton, indicating chitin. Internally, the main organs are located within the organ 
cavity (hemal space). The hepatopancreas, intestine and gonads are the three principal organs that 
were observed in the histological screens through the mid-body plan. The gonads are localized on 
the dorsal zone, but in case of the gonads of females at more advanced maturation stages, these 
were observed to occupy the entire space around the intestine and hepatopancreas. Typically, 
females were found to be in a more advanced stage of maturation than males. The principal target 
organ of the present study, the hepatopancreas, is responsible for the digestive, absorption and 
excretory functions. The hepatopancreas was observed to be composed of four tubules 
(diverticula), located around and along the intestine, with a similar structure as that described by 
Correia et al. (2002). The tubules consisted of circular structures constituted by a single-cell layer 
epithelium surrounding the lumen (Figure 1 B). Both the lumen of tubules and the lumen of the gut 
contained AB-positive (blue) substances, indicating the presence of acidic polysaccharides, likely 
from the ingestion of algal material.  
 
 
Figure 1 – Gammarus locusta: internal description of a blank animal, transversal mid-body section fixed on 
Carnoy and stained for TC stain. A: Description general of mature female, with eggs (eg) on marsupial sac 
between pereopods (per); was visible the external chitin exoskeleton (c), the muscle (msc), ventral nerve 
cords (vnc); on mid-body plan was visible the intestine (int) surrounded by hepatopancreas tubules (hp) and 
gonads (gn) and hemolymphatic vessel (hv) on dorsal zone. B: Hepatopancreas tubule, with a single-cell 
layer epithelium (ep) surrounding the lumen (lu) and lined by the basal lamina (bl). The main organs were 
located in the hemal space (hs) 
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The comparison between AO- and TC-stained samples permitted a good differentiation between 
the three epithelial cell types. F-cells had a fibrillar appearance, resulting from a well-developed 
rough endoplasmic reticulum, indicating active enzyme synthesis, since ribosomal RNA confers to 
the cells a reddish coloration when stained with Acridine Orange (AO) (Figure 2 A) and brownish 
from Weigert’s Hematoxylin used in the TC stain (Figure 2 B). The F-cells normally did not have 
vacuoles, but sometimes one or two vacuoles could be observed, possibly associated to the 
differentiation into B-cells. B-cells (Figure 2 C, D), on their turn, were characterized by a single 
large vacuole occupying the cytoplasm almost entirely. These vacuoles contained AB-positive 
material (Figure 2 D), thus likely associated to digestion. R-cells had numerous vacuoles which 
contributed to the focal enlargement of cells and subsequently increased epithelium thickness. The 
cells presented a bright pink staining from the PAS-Schiff’s reaction (TC stain), typically 
associated to glycogen storage (Figure 2 B), and were mainly AO metachromatic (yellowish) 
(Figure 2 A), indicating metabolically highly active cytoplasms containing densely packed 
materials and organelles. 
 
 
Figure 2 – Gammarus locusta: description of hepatopancreas epithelial cells of blank animals. A: Epithelial 
cells of an animal fixed in Bouin-Hollande’s solution and stained for AO stain. The R-cells (R), with 
numerous non-digestive vacuoles (ndv) presenting AO metachromasia, indicative of nuclear DNA. The F-
cells (F) presented AO ortochomasia indicative of nuclear RNA and a developed endoplasmic reticulum.                    
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Some hemocytes (he) are visible, yielding high positive AO metachomasia B: Epithelial cells (TC stain) of 
an animal fixed in Carnoy’s. R-cells (R) presented a bright pink staining from the PAS-Schiff’s reaction, 
indicative of glycogen storage, and F-cells (F) presented a brownish staining from Weigert’s Hematoxylin, 
indicative of a well-developed endoplasmic reticulum occupying most of the cytoplasm. C: Epithelial cells in 
an animal fixed in Bouin-Hollande’s solution and stained with AO. The B-cells (B) hold a large digestive 
vacuole (dv) responsible by intracellular digestion. D: Epithelial cells of an animal fixed in Carnoy’s and 
stained with TC. The digestive vacuole (dv) in B-cells (B) revealed AB-positive undifferentiated materials. 
The cells’ nuclei (nu) was stained brownish from Weigert’s Hematoxylin reaction in panels B and D; and AO 
metachromatic (yellowish) in panels A and C. Hemal space (hs); lumen (lu). 
 
4.2. Histopathological alterations  
 
No gross histopathological lesions were observed in any of the organs analyzed (hepatopancreas, 
gonads and muscle) for both males and females, including blanks (B) and controls (C). Also, the 
qualitative histopathological evaluation showed only few cases of infiltrating hemocytes (Figure 
3B, C), in animals subjected to all treatments, also including blanks (B) and controls (C), without a 
clear trend concerning exposure concentration. The individuals did not present necrotic foci in any 
of the organs subjected to histological analyses.  
 
 
Figure 3 – Histopathological alterations on Gammarus locusta exposed to simvastatin. A: Indication of 
quantitative biomarkers in hepatopancreas tubule of animal exposed to 0.064 μg.L
-1
 simvastatin 
concentration; fixed on Bouin-Hollande’s solution and stained with AO: mean non-digestive vacuole 
diameter (MVD) and mean epithelium thickness (MET). The mean number non-digestive vacuoles was 
determined by counting non-digestive vacuoles (ndv). B: Hemocytes (he) infiltrating in muscle tissue (msc) 
of an animal exposed to 0.32 μg. L-1 simvastatin (Bouin-Hollande’s, AO stain). C: Hemocytes (he) 
aggregating in the hemal space of blank animal (Bouin-Hollande’s, TC stain). 
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The quantitative histopathological evaluation (Figure 3 A) revealed alterations in the thickness of 
tubular epithelia (measured in areas where visible accumulation of vacuoles did not occur to avoid 
biasing from vacuolation), non-digestive vacuole diameter, number of vacuoles (non-digestive) and 
cell type ratio, associated to simvastatin concentrations. The mean epithelial thickness of the 
hepatopancreas (for both males and females) varied with the concentration of exposure, however, 
this variation was not monotonic, increasing up to exposure concentrations of 0.064  and 0.32 μg.L
-
1
 , decreasing at higher concentrations of exposure (Figure 4 A). However, this variation was more 
pronounced in females (Figure 4 A). Statistical analyses revealed significant differences in the 
thickness of tubular epithelia between the group exposed to 0.064 μg.L
-1
, with a mean thickness of 
21.64 ± 6.14 μm and the group exposed to 8 μg.L
-1
, with a mean thickness of 14.79 ± 1.99 μm 
(males and females combined) (Mann-Whitney U, p < 0.05). 
 
Non-digestive vacuole diameter (Figure 4 B) decreased with increasing simvastatin concentrations. 
The mean vacuole diameter presented a significant difference between the control group (C) with a 
mean vacuole diameter of 7.29 ± 2.27 μm and the group exposed to concentration of 8 μg.L
-1
 with 
a mean vacuole diameter of 4.90 ± 0.95 μm, combining females and males. Females had a more 
regular decrease in mean vacuole diameter than males, from controls to higher simvastatin 
concentration (8 μg.L
-1
). There was a significant difference between females and males to 
concentration of 0.064 μg.L
-1
, with the vacuole diameter being higher in females (Mann-Whitney 
U, p < 0.05). 
 
On the other hand, the mean number of non-digestive vacuoles (Figure 4 C) per cell did not present 
significant differences between exposure treatments and controls, combining males and females. 
However, a few females had R-cells with more numerous vacuoles, usually between four or six per 
cell. Nonetheless, only controls yielded significant differences between females and males (Mann-
Whitney U, p < 0.05). The group exposed to the simvastatin concentration of 1.6 μg.L
-1
, and only 
for females, presented a significant decrease in the average number of vacuoles, compared to all 
other treatments.  
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Figure 4 – Mean results per simvastatin nominal concentration, males and females combined (left) and 
separated (right) .A: Thickness of tubular epithelia. B: Non-digestive vacuole diameter C: Number of non-
digestive vacuoles per epithelial cell. Different letters mean significant differences (Mann–Whitney U test, p 
< 0.05); latin letters for males results and greek letters for females results. (*) significant difference between 
males and females. B – blank; C – control (solvent only). 
 
F-cells were more abundant in tubular epithelia that R-cells, and B-cells were the least numerous 
(Figure 5 A). Apparently, the F-cells ratio (Figure 5 D) presented few variations between 
treatments and control group, for either males or females. R-cells ratio (Figure 5 C) increased with 
simvastatin concentrations in males but not in females. The B-cells ratio (Figure 5 B) was higher in 
animals exposed to the concentration of 0.064 μg.L
-1
  and decreased with the following simvastatin 
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concentrations, for both sexes. However, cell ratios did not reveal significant differences between 
treatments and control group except the F-ratio for the concentration of 0.32 μg.L
-1
, for females 
(Figure 5 D). There was a significant difference between females and males in control group 
regarding the R-ratio, being higher in females (Mann-Whitney U, p < 0.05). 
 
Figure 5 – Mean of cell ratios per simvastatin concentration. A: Cell ratios per cell type, for males and 
females combined. B: B-cell ratio. C: R-cell ratios. D: F-cell ratios. Different letters mean significant 
differences (Mann–Whitney U test, p < 0.05); latin letters for males ratios and greek letters for females ratios. 
(*) significant difference between males and females. B – blank; C – control (solvent only). 
 
4.3. Multivariate analyses  
 
Correlations between all variables, independently of sex and simvastatin concentrations, are 
presented in Table 1. The F- and R-ratios yielded the most significant (negative) correlation 
(Spearman‘s rank-order correlation R= -0.8527, p < 0.05), as expected. The mean epithelium 
thickness (MET) presented a significant positive correlation with mean non-digestive vacuole 
diameter (MVD) and number (MVN) (R > 0.4 and p < 0.05).  
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Table 1 - Spearman’s rank-order correlation R statistics (all biological variables). Highlighted statistics are 
significant at p < 0.05. 
 
MET MVD MVN R-ratio B-ratio F-ratio 
MET 1.0000 
     
MVD 0.4121 1.0000 
    
MVN 0.4348 0.3438 1.0000 
   
R-ratio 0.2126 0.1843 0.3184 1.0000 
  
B-ratio -0.1500 0.1702 0.0358 -0.2869 1.0000 
 
F-ratio -0.1088 -0.2722 -0.3007 -0.8527 -0.1461 1.0000 
MET – mean epithelium thickness; MVD – mean non-digestive vacuole diameter; MVN – mean non-
digestive vacuoles number; R-ratio – R-cell ratio; B-ratio. – B-cell ratio; F-ratio – F-cell ratio;  correlation 
> 0.4;  correlation > 0.5. 
 
The survival rate was variable, ranging between the averages of 15 and 51% for females; and 
between 7 and 43% for males. The correlations between survival rates and simvastatin 
concentrations only yielded a significant and negative correlation in males (R= -0.4650, p < 0.05). 
The survival rates for simvastatin treatments were similar to those of the control groups, without a 
clear trend, either dose-dependent. Females presented a maximum survival rate for 0.064 μg.L
-1
 
simvastatin and males presented a maximum survival rate for the concentration of 0.32 μg.L
-1
. 
 
Principal component analysis (PCA) for all individuals (Figure 6 A), independently of sex, 
retrieved two factors that, combined, explained over 60% of the total variance. The first principal 
component factor explained 37.26% of the total variance and the second principal component 
explained 24.24%. The F-ratio revealed a positive link with nominal concentration of simvastatin, 
unlike the R-ratio which presented a negative relationship. Nominal concentrations, epithelium 
thickness (MET) and vacuole number (MVN) were positively linked.  
 
Females presented a first principal component factor that explained 45.42% of the total variance 
and a second that explained 18.94% (Figure 6 B). On total, the two factorial axes explained over 
64% of total variance. Epithelium thickness (MET) and vacuole diameter (MVD) presented 
negative relations whit nominal concentrations of simvastatin. Males presented a fist principal 
component which explained 35.96% of the total variance and a second principal component which 
explained 27.58% (Figure 6 C).On total, the two factorial axes explained over 63% of total 
variance. The mean epithelium thickness (MET) and vacuole number (MVN) presented negative 
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correlations whit nominal concentrations. Unlike the females, the R-ratio and nominal 
concentrations yielded a positive relation in males. 
 
Figure 6 – Principal component analysis (PCA). A: PCA for both males and females together. B: PCA for 
females. C: PCA for males.  supplementary variable;  active variable. MET – mean epithelium thickness; 
MVD – mean non-digestive vacuole diameter; MVN – mean non-digestive vacuoles number; R-ratio – R-cell 
ratio; B-ratio. – B-cell ratio; F-ratio – F-cell ratio. 
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5. Discussion 
 
Simvastatin concentrations that were tested in the present study revealed a trend to induce 
alterations in metabolic processes, rather than severe histopathological lesions or significant 
morphological alterations, in the organs present in mid-body sections of the amphipods. The drug 
affected mainly the hepatopancreas epithelial cells, reflecting alterations that are consistent with 
physiological and metabolic alterations; such as the F-cell ratio that appear positive dose-dependent 
or epithelium thickness and non-digestive vacuole diameter that appears to be negatively dose-
dependent of simvastatin concentrations (Figure 6 A). However, for some of the measured effects, 
the response curve is not monotonic, such as for changes in epithelial thickness which appear to 
increase from blanks and controls to the lower exposure concentrations, and decrease linearly to 
higher concentrations (Figure 4 A); and number of intracellular non-digestive vacuoles which 
presented the same trend of thickness. Interestingly these two biomarkers were found highly 
correlated (Table 1), even though the measurements were made in areas of non-vacuolated cells, in 
order to avoid biasing. Between males and females moderate but significant differences occurred in 
the surveyed histopathological biomarkers, as R-cells ratio (Figure 5 C), probably associated to 
sexual dimorphism in basal carbohydrate metabolism and energy reserves. 
 
In most animals, simvastatin acts by inhibiting the enzyme 3-hydroxy-3-methylglutaryl-coenzyme 
A (HMG-CoA) reductase, the enzyme that permits the conversion of Acetyl-CoA to mevalonate, a 
precursor of cholesterol (Mauro, 1993; Desager and Horsmans, 1996; Patil et al., 2007; Key et al., 
2008). In vertebrates, best described in mammals, the organ that simvastatin affects more directly is 
the liver, where the drug is biotransformed to several metabolites by cytochrome P450 (CYP), such 
as simvastatin acid, which intervenes in cholesterol biosynthesis by HMG-CoA reductase inhibition 
(Mauro, 1993; Patil et al., 2007). Following the addition of squalene (a precursor of cholesterol), 
the mevalonate pathway results in other products: ubiquinone (coenzyme Q), an antioxidant 
substance that is also important in the electron transport chain of mitochondria by permitting 
electron transport from NADH to citochrome c; dolichol, with the function of oligosaccharide 
transport to proteins synthesized in endoplasmic reticulum (protein glycosylation); isopentenyl 
adenosine, that interferes in t-RNA modification and protein synthesis; and farnesyl diphosphate 
and geranylgeranyl diphosphate, important intermediate compounds for the synthesis of proteins 
(Gerson et al., 1989; Desager and Horsmans, 1996; Bentinger et al., 2010). 
 
In invertebrates, namely in crustaceans, the hepatopancreas is the analogous organ to the vertebrate 
liver. It is responsible for xenobiotic detoxification between other functions, such as digestion, 
protein synthesis, secretion and enzyme synthesis, storage and carbohydrate metabolization and it 
is highly sensitive to polluting agents (Saravana Bhavan and Geraldine, 2000; Correia et al., 2002; 
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Wu et al., 2008; Walker et al., 2010). Accordingly, Walton and Pennock (1972) reported that the 
mevalonate pathway in invertebrates is similar to the process described for vertebrates, however, 
sterols, in crustaceans, are mostly acquired from diet. Furthermore, Desager and Horsmans (1996) 
concluded that simvastatin also decreases acyl coenzyme A acyltransferase (ACAT) activity, which 
is responsible for cholesterol uptake directly from the diet, so simvastatin may reduce the contents 
of cholesterol and similar compounds in invertebrates. Still, it must be notes that these processes 
are variable between taxaonomic groups. For instance, Chang (1995), in a study with the nematode 
Caenorhabditis elegans described the mevalonate pathway with production of the coenzyme Q, 
dolichol and precursors of proteins synthesis, but not squalene. In amphipods, the simvastatin 
effects are little known and the abovementioned processes are less studied, but it probably is 
similar to the pathways described by Walton and Pennock (1972) for crustaceans Carcinus maenas 
and Eupagurus bernhardus, and Chang (1995) for the nematode C. elegans. 
 
There are contradictions in relation to the simvastatin effects, which probably are connected with 
several variables such as concentration, exposure method and assay conditions. Nevertheless, the 
present study showed that the drug affected cellular metabolism, with consequences at the 
histological level. Altogether, these results indicate that simvastatin hardly affects only the 
mevalonate process, but rather those directly or indirectly connected to Acetyl-CoA. As such, ATP 
production through the Krebs cycle, where the Acetyl-CoA is a precursor of citric acid (Junqueira 
and Carneiro, 2004), as well as the synthesis of triglycerides (Steinberg et al., 1961), are some of 
the processes that are probably altered by simvastatin exposure, which aids explaining the 
physiological changes endured in G. locusta exposed to the drug, leading to alterations in the 
epithelia of the hepatopancreas. The trend to increase the number of non-digestive vacuoles (which 
are devoid of inclusions or PAS-positive substances), in animals exposed to the lower simvastatin 
concentrations (0.064 and 0.32 μg.L
-1
) suggest an increase of lipid storage (i.e. lipid that is washed-
off during sample processing) in tubule epithelial cells, probably triglycerides or other hydrophobic 
reserve carbohydrates. This storage is probably associated to simvastatin inhibition of the HMG-
CoA reductase, therefore hampering Acetyl-CoA transformation into mevalonate, then permitting 
an increase of Acetyl-CoA concentration in cell. Consequently, the excessive Acetyl-CoA may be 
used in other processes as fatty acid/triglyceride synthesis, as well was described in mammals by 
Desager and Horsmans (1996) where simvastatin improves the production of triglycerides and its 
storage in the liver (reverse cholesterol transport). In amphipods, this process occurs in 
hepatopancreas, which aids explaining the increased formation of lipid storage vacuoles, at least for 
lower concentrations of exposure. In fact, the triglycerides are the principal storage lipids in 
amphipods (Clarke et al., 1985). 
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The present results revealed a possible increase in this metabolic processes, for the two lower 
concentrations (0.064 and 0.32 μg.L
-1
), which is visible through the increase in epithelium 
thickness (Figure 4 A) and number of non-digestive vacuoles (Figure 4 C). The increase of 
epithelium thickness is probably associated to endoplasmic reticulum development related to 
elevated enzyme production as a defense response for the metabolization and elimination of 
simvastatin. In relation, the trend to increase the number of non-digestive vacuoles is probably 
associated to up-regulated metabolic processes that permitted an increase in lipid storage, namely 
triglycerides. Conversely, higher concentrations of exposure (1.6 and 8 μg.L
-1
) yielded negative 
responses, which may now be associated to deregulation of basal metabolic processes, especially 
those related to energy production and carbohydrate metabolism, leading to either decreased lipid 
production of increased lipid catabolism, or a combination of both. Consequently the storage of 
hydrocarbons in hepatopancreas (free sugars and lipids and hydrocarbons stored in R-cells) 
decreased such as has been observed by Dahl et al. (2006), who stated that copepods used lipid 
reserves to produce energy to promote survival to higher simvastatin concentrations. Also, it must 
be noticed that, in aerobic energy production pathways, the Krebs cycle and the electron transport 
chain stand out as the most critical processes, the former being able to be disrupted by the drug via 
changes to acetyl-CoA availability. As such, unbalancing the processes likely results in increasing 
intracellular levels of reactive oxygen species, leading to oxidative stress (Bentinger et al., 2010). 
This instability has probably been responsible, at least in part, by the reduction of the enzymatic 
system followed by decreasing endoplasmic reticulum and consequent decrease of epithelium 
thickness.  
 
The bi-tonic dose-response curves in this study are similar to those described by Dahl et al. (2006) 
and Key et al. (2008). Dahl et al. (2006) described, in copepods, that RNA contents would increase 
for simvastatin concentrations up to 0.16 μg.L
-1
, followed by decrease in animals exposed to higher 
concentrations of the drug. Interestingly, RNA contents may hold a relation with epithelium 
thickness, through changes in ribosome RNA (rRNA) contents, thus affecting, for instance, enzyme 
production and all other processes involving protein biosynthesis. Also, Key et al. (2008) disclosed 
acute effects of simvastatin in grass shrimp and observed that the lipid peroxidation was higher for 
lower concentrations of simvastatin, decreasing significantly for higher concentrations of exposure. 
Conversely, the diameter of non-digestive vacuoles (Figure 4 B), unlike the two biomarkers 
mentioned above, presents a monotonic curve, albeint presenting a trend to decrease with 
increasing of simvastatin concentrations, which may imply decreased storage. 
 
The antioxidant ability in cells may be regulated by coenzyme Q, as observed for mammals by 
Velho et al. (2006) and Bentinger et al. (2010) and in crustaceans by Walton and Pennock (1972). 
In the livers of murine models exposed to lovastatin, a statin drug similar to simvastatin, Velho et 
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al. (2006) observed toxic effects associated to coenzyme Q inhibition that contributed to break the 
electron chain in mitochondrial respiration, decreasing ATP production and increasing oxidative 
stress. The same authors also observed a dose-dependent relationship between exposure to 
lovastatin and elevated intracellular Ca
2+
, consequently increasing mitochondria membrane 
permeability. The increased permeability of the mitochondrial membrane increases the probability 
of occurring cytochrome c release, which is one of the triggers of apoptosis (Bentinger et al., 2010). 
In accordance, in human cells, Werner et al. (2004) found a dose-response curve between 
simvastatin exposure and caspase activation that induced apoptosis. However Parihar et al.(2011), 
on another study in rats about the effects of statins, including simvastatin, observed decreased 
mitochondrial oxidative stress in liver cells and decreased Ca
2+
 levels, thus preventing membrane 
permeability and the release of cytochrome c to the cytoplasm. The same authors observed that 
simvastatin contributes to lowering lipid peroxidation and decreased concentration of reactive 
oxygen species in the cell. In the current study apoptosis was not observed but the critical 
metabolic alterations in hepatopancreas may indicate that simvastatin is particularly toxic to the 
species by affecting multiple metabolic processes related to energy balance and oxidative stress. 
 
The epithelium cells of hepatopancreas tubules (diverticula) have several functions, each cell type 
being specialized in one or multiple processes. Three main cell types were observed in this study, 
namely, B-, F- and R-cells; however some authors describe the existence of other epithelium cell 
types in the crustacean hepatopancreas, such as E- (embryonic) cells, undifferentiated cells that 
divide mitotically in R- and F-cells to replace dead cells (Al-Mohanna et al., 1985); and M- 
(midget) cells that have a similar storage function to the R-cells but are responsible for the storing 
of glycol-protein materials and glycogen (Al-Mohanna and Nott, 1987). Nevertheless, E- and M-
cells were not observed in the present work. 
 
The cell ratios (relatively to the total number of epithelial cells), especially those for F- and R-cells, 
supported the identification of simvastatin exposure effects and are most likely linked to metabolic 
alterations. Combining males and females (Figure 6 A), principal component analysis (PCA) 
revealed that the ratio of F-cells was positively correlated with simvastatin concentrations while, 
and at the same time, the ratio of R-cells presented a negative correlation with the concentration of 
the drug. Although the cell ratios, in the current results, failed to reveal much significant variations, 
it is important to refer that an increase of the F-cell ratio should mean an increase in the production 
of digestive enzymes (Al-Mohanna et al., 1985). Also, this effect may reflect changes in the 
digestion process since the B-cell ratio, responsible for intracellular digestion (Al-Mohanna and 
Nott, 1986), also presented a positive correlation with the simvastatin concentration.  
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The R-cells, in crustaceans, are associated to the storage of glycogen and lipids, to which are added 
important detoxification functions (Al-Mohanna and Nott, 1987). The presence of undifferentiated 
glycogen deposits in the cytoplasm (but not in vacuoles) was visible through the PAS-Schiff’s 
reaction (in TC stained-samples). Food items are processed in the lumen of the hepatopancreas, 
where, through pinocytosis, B-cells assimilate food particles that will undergo intracellular 
digestion (Al-Mohanna and Nott, 1986), an evolutionary archaic process that persists in many 
invertebrate animals. After intracellular digestion, the small molecules are diffused to the 
haemolymph while undigested materials are exocytized to the lumen, some of this for elimination 
(Al-Mohanna and Nott, 1986). After, the R-cells’ role is to assimilate substances and partly 
digested materials from both the haemolymph and the lumen of tubules, by diffusion or 
pinocytosis. All the material is processed in the cells’ cytoplasm to originate lipids and glycogen, 
which are used in several metabolic processes (Al-Mohanna and Nott, 1987). The surplus lipids are 
stored in the non-digestive vacuoles that are numerous in R-cells (cells’s main carbohydrate 
reserve). As mentioned above, non-digestive vacuoles were not stained by any histochemical 
technique, suggesting lipid contents. However, it should not be disregarded that non-digestive 
vacuoles can contain contaminants and/or their metabolites, as simvastatin (see Al-Mohanna and 
Nott, 1987). In accordance, PCA analyses revealed a negative correlation between simvastatin 
concentration and the R-cell ratio (Figure 6 A), which can be associated to a depletion of lipid 
reserves. 
 
Moderate differences were observed between males and females suggesting some degree of sexual 
dimorphism in amphipods associated to higher energy reserves, namely lipids and glycogen, in 
females than males, which is in accordance with the findings by Sroda and Cossu-Leguille (2011) 
and Gismondi et al. (2012) in another amphipod, Gammarus roeseli. In the present study, females 
presented a significantly higher mean number of non-digestive vacuoles (Figure 4 C) as well as the 
R-cell ratio (Figure 5 C) on control group than males that suggest a higher lipid reserves in females 
hepatopancreas under normal circumstances. Even at the lower concentration of exposure (0.064 
μg.L
-1
), the diameter of non-digestive vacuoles (Figure 4 B) was larger in female epithelial cells. 
These results are in agreement with the premise that females have a higher natural capacity to store 
lipids, which is probably associated to the high energetic demand of reproduction (Sroda and 
Cossu-Leguille, 2011). In fact, females, when maturity is being reached, tend to accumulate high 
amounts of lipids, which are essential for egg production (Clarke et al., 1985). It should be notes 
that, in the present study, the females were already at a late stage of sexual maturation, with well 
develop gonads and, inclusively, some already held mature eggs in their marsupial sac (Figure 1 
A).  
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The differences between males and females associated to simvastatin exposure also revealed some 
degree of sexual dimorphism in relation to the ability to respond of toxicological stress. In fact, the 
survival evaluation reveled that males are more affected by simvastatin than females, given that 
presents a decrease of the survival rate with increasing exposure concentrations. However, the 
survival rates for simvastatin did not have a clear trend (dose-dependent), which indicates that 
acute effects of the drug onto the species have yet to be understood. In addition, the F-cells ratio in 
females increased up to exposure to 0.32 μg.L
-1
 in comparison to the control group, unlike males, 
who failed to exhibit significant alterations in this ratio (Figure 5 D). In fact, it has been suggested 
that females have a more pronounced defense ability towards contamination than males (Sroda and 
Cossu-Leguille, 2011; Gismondi et al., 2012). Furthermore, the increase of F-cell ratio is probably 
associated to elevated enzyme synthesis and secretion (see Al-Mohanna et al., 1985), some of 
which may participate in antioxidant defense or contaminant catabolism and elimination. In fact, 
amphipods females presented a large antioxidant defense that was demonstrated by Sroda and 
Cossu-Leguille (2011) and Gismondi et al. (2012) when found higher values of glutathione in 
Gammarus roeseli females than males. Also, in accordance, the PCA results for females (Figure 6 
B) revealed a positive correlation between simvastatin concentration and the F-cell ratio, whereas 
was strikingly the opposite for males (Figure 6 C). The current results also showed that epithelium 
thickness (Figure 4 A) was unchanged in males, which indicates unaltered metabolism. 
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6. Conclusions 
 
The present study revealed that simvastatin affects carbohydrate metabolism and storage in the 
amphipod Gammarus locusta. Also, it has been shown that the hepatopancreas was the main organ 
affected by simvastatin. The reason of this preferential localization of the alterations is probably 
due to the fact that hepatopancreas is a particularly active organ, having many functions such as the 
digestion process, protein and enzyme synthesis, storage and carbohydrate metabolization, and 
organism decontamination. Some physiological alterations in the hepatopancreas epithelium 
presented a moderate dose-dependent relation with simvastatin concentration, especially 
concerning epithelium thickness, probably evidencing a variation in the development of the 
endoplasmic reticulum and, consequently, enzyme production and activity. Also importantly, the 
number and diameter of non-digestive vacuoles evidenced that lipid reserves tend to deplete with 
the increasing of simvastatin concentration. Nevertheless, it has been shown that the dose-response 
curves are not-monotonic for most of the measured endpoints, rather showing that higher 
concentrations tend to impair metabolism, with consequences at the histopathological level.  
 
Another important point in this study concerns the differences between males and females in 
relation to ability to respond to simvastatin exposure. Females appear to respond more actively than 
males, which is likely associated to the higher energy reserves and demand, as verified by 
increasing number and diameter of the non-digestive vacuoles in females.  
 
The current findings thus suggest that, in Gammarus locusta, simvastatin affects primarily the 
cellular metabolism. As such, in the future, it would be important to develop further studies with 
the drug to survey other endpoints such as those related to oxidative stress, cholesterol contents, 
etc., and to correlate with histological findings. Yet another important approach would be the 
evaluation of development and growth following exposure to simvastatin, which are probably the 
most sensitive biological processes to changes in basal physiological functions.  
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